San Diego-based mostly Viking Therapeutics marked itself as a serious competitor during the weight loss drug sector in February immediately after revealing promising info from a mid-phase trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when offered being a weekly injection As well as in March